WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Fabrizio Mattei
PeerJ Editor
570 Points

Contributions by role

Editor 570

Contributions by subject area

Bioinformatics
Molecular Biology
Oncology
Respiratory Medicine
Medical Genetics
Biochemistry
Cell Biology
Histology
Pharmacology
Immunology
Infectious Diseases
COVID-19
Women's Health
Microbiology
Gastroenterology and Hepatology

Fabrizio Mattei

PeerJ Editor

Summary

Dr. Fabrizio Mattei graduated from University “La Sapienza” in Rome and completed his specialization in biotechnologies and oncology at the same university. In 2000, he became a fellow at the Edward Jenner Institute for Vaccine Research in David Tough's laboratory (Newbury, U.K.), where he acquired experience in the field of dendritic cell immunology. He is currently a Researcher, Group Leader and Principal Investigator at the Istituto Superiore di Sanità (Rome, Italy), where he has focused on the molecular interactions between dendritic cells and type I Interferons signalling.
His current research is aimed at understanding the role of Interferons signalling and IL-33 in the interface between tumor and immune system in both mouse and human models. Furthermore, he is also conducting research aimed at investigating on crosstalk between immune system and cancer by Cell-on-Chip devices. In addition, Dr. Mattei is developing a multidisciplinary laboratory network focused at the realization of Organ-On-Chip platforms, useful to mimic and study human diseases and cancer.

Cell Biology Immunology Oncology Pharmacology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Work details

Researcher & Group leader

Istituto Superiore di Sanità
Deprtament of Oncology and Molecuar Medicine.

Websites

  • Google Scholar
  • ResearcherID
  • Mattei's professional profile

PeerJ Contributions

  • Edited 4

Academic Editor on

June 10, 2025
Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiota
Yu Gan, Hao Yang, Maijian Wang, Jida Li
https://doi.org/10.7717/peerj.19535 PubMed 40520636
March 14, 2022
3,4-dihydroxyphenylethyl alcohol glycoside reduces acetaminophen-induced acute liver failure in mice by inhibiting hepatocyte ferroptosis and pyroptosis
Tianyu Liu, Lei Yang, Hejun Gao, Yuzhen Zhuo, Zhengwei Tu, Yongqin Wang, Jing Xun, Qi Zhang, Lanqiu Zhang, Ximo Wang
https://doi.org/10.7717/peerj.13082 PubMed 35310165
March 9, 2022
Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
Mohd Zulkifli Salleh, Mohd Nor Norazmi, Zakuan Zainy Deris
https://doi.org/10.7717/peerj.13083 PubMed 35287350
September 17, 2021
Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis
Min Liu, Fei Mo, Xiaohan Song, Yun He, Yan Yuan, Jiaoyan Yan, Ye Yang, Jian Huang, Shu Zhang
https://doi.org/10.7717/peerj.12147 PubMed 34616615